Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,050 | -4,349 | -10,488 | -11,105 | -11,618 |
| Accounts receivable | N/A | N/A | N/A | -13 | -26 |
| Other Working Capital | 502 | 340 | -290 | 860 | 12 |
| Other Operating Activity | 1,175 | 889 | 1,327 | 3,131 | 5,394 |
| Operating Cash Flow | $-5,373 | $-3,120 | $-9,451 | $-7,127 | $-6,238 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | -3,000 | -3,000 | -2,000 |
| Investing Cash Flow | $N/A | $N/A | $-3,000 | $-3,000 | $-2,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,716 | 4,973 | 7,526 | 3,651 | 3,101 |
| Other Financing Activity | -1,207 | -442 | 0 | -71 | 0 |
| Financing Cash Flow | $8,509 | $4,531 | $7,526 | $3,580 | $3,101 |
| Beginning Cash Position | 1,783 | 1,783 | 6,708 | 6,708 | 6,708 |
| End Cash Position | 4,919 | 3,194 | 1,783 | 161 | 1,571 |
| Net Cash Flow | $3,136 | $1,411 | $-4,925 | $-6,547 | $-5,137 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,373 | -3,120 | -9,451 | -7,127 | -6,238 |
| Free Cash Flow | -5,373 | -3,120 | -9,451 | -7,127 | -6,238 |